メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
東北大学 ホーム
ヘルプ＆FAQ
English
日本語
ホーム
プロファイル
研究部門
研究成果
プレス/メディア
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
眞野 成康
教授
大学病院 (科・部等に属さない)
h-index
5066
被引用数
36
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
1992 …
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(297)
プレス/メディア
(7)
類似のプロファイル
(6)
フィンガープリント
Nariyasu Manoが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Chemistry
Tandem Mass Spectrometry
100%
Bile Acid
87%
Electrospray Ionization
78%
Liquid Chromatography
67%
Metabolite
52%
Liquid Chromatography Tandem Mass Spectrometry
36%
Mass Spectrometry
32%
High-Pressure Liquid Chromatography
30%
Enantiomer
30%
Mobile Phase Composition
28%
CID
25%
Collisionally Activated Dissociation (CAD)
24%
Biological Marker
22%
Flavoprotein
21%
Deoxycholic Acid
20%
Chirality in Separations
17%
Acetonitrile
17%
Methanol
15%
Pharmacokinetics
15%
Glucoside
14%
Liquid Chromatography Mass Spectrometry
14%
Cytochrome P450
13%
Antineoplastic Agent
12%
hydroxylation
12%
Liquid Chromatography Mass Spectrometry (LCMS)
12%
Bile Acid Metabolite
12%
Derivatization
11%
Hydroxyl Group
11%
Chromatography
11%
Deoxycholate
11%
N-Oxide
10%
Analytical Calibration
10%
Binding Site
10%
Taurine
10%
Chenodeoxycholic Acid
10%
Amino Acid
10%
Buffer Solution
10%
Diastereomer
9%
Amino Group
9%
Isolation Method
9%
Enantioselectivity
9%
Sulfate
8%
Cholic Acid
8%
Ruthenium
8%
Galactoside
8%
Coenzyme A
8%
Binding Protein
8%
Electrospray Ionization Mass Spectrometry
7%
Affinity Label
7%
Two-Dimensional NMR
7%
Pharmacology, Toxicology and Pharmaceutical Science
Bile Acid
80%
Electrospray Ionization
43%
Adverse Drug Reaction
40%
Therapeutic Drug Monitoring
39%
Biological Marker
38%
Diseases
37%
Renal Cell Carcinoma
37%
Polypeptide
32%
Chenodeoxycholic Acid
26%
High Performance Liquid Chromatography
24%
Sunitinib
23%
Congenital Malformation
23%
Pharmacokinetics
22%
Adenosine Phosphate
22%
Prevalence
22%
Deoxycholic Acid
20%
Glucuronide
18%
Antihypertensive Agent
18%
Rapamycin
17%
Malignant Neoplasm
16%
Organic Anion Transporter
15%
Adverse Event
15%
Liver Cell Carcinoma
14%
Nonalcoholic Fatty Liver
13%
Anticancer Drug
13%
Paclitaxel
13%
Drug Interaction
13%
Protein Tyrosine Kinase Inhibitor
13%
Bile Acid Conjugate
12%
Sorafenib
12%
Sulfate
11%
Cholic Acid
11%
Flavoprotein
11%
Mycophenolic Acid
11%
Clozapine
11%
CYP3A4
11%
Antihypertensive Drug
10%
Acetonitrile
10%
Folic Acid
10%
Flurbiprofen
10%
Amlodipine
10%
Niemann Pick Disease
10%
Hydroxyl Group
10%
Warfarin
10%
Pharmacotherapy
9%
Side Effect
9%
Adenosine Triphosphate
9%
Lithocholic Acid
8%
Binding Site
8%
Prostaglandin
8%
Biochemistry, Genetics and Molecular Biology
Metabolite
50%
Bile Acid
42%
Tandem Mass Spectrometry
42%
Mass Spectrometry
33%
Electrospray Ionization
30%
Blood Plasma
27%
Liquid Chromatography-Mass Spectrometry
24%
Niemann-Pick Disease
20%
Quantitative Technique
19%
Blood Pressure
18%
Blood Level
15%
Electrospray Ionization
14%
Metabolomics
14%
Sunitinib
14%
Deoxycholic Acid
13%
Wild Type
12%
High-Performance Liquid Chromatography
11%
Tandem Mass Spectrometry
11%
Hydroxylation
11%
CYP2B6
10%
Lipid
9%
Tyrosine Kinase Inhibitor
9%
Enzyme Activity
8%
Anticancer
8%
Collision-Induced Dissociation
8%
Autosomal Recessive Disorder
8%
Lipidomics
8%
Binding Protein
7%
Epimer
7%
Cancer Cell
7%
Enzyme
7%
Adenosine Triphosphate
7%
Metabolic Pathway
7%
ATP-binding Cassette Transporter
7%
ABC Transporter
7%
Electrospray Mass Spectrometry
7%
S-Nitrosylation
6%
Protein Disulfide-Isomerase
6%
Flavoprotein
6%
Dihydropyrimidine Dehydrogenase
6%
CYP3A4
6%
Fluorouracil
6%
Time-of-Flight Mass Spectrometry
6%
Phosphorylcholine
6%
Pharmacokinetics
5%
Oxidative Stress
5%
DPYD
5%
Intrinsic Clearance
5%
Adenosine Monophosphate
5%
Mitochondrial Disease
5%
